New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Humacyte, Inc.
HUMA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

354M

Biotechnology

Next Earning date - 12 Aug 2025

354M

Biotechnology

Next Earning date - 12 Aug 2025

2.28USD

Shape0.19 ( 9.09%)
Market Closed (as of Jul 01, 20:00 EDT)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

11%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated July 2, 2025
1W 2.70 % 1M -12.64 % 3M 57.24 % 1Y -59.79 %

Key Metrics

Shape
  • Market Cap

    353.67M


  • Shares Outstanding

    155.12M


  • Share in Float

    125.45M


  • Dividende

    0


  • Earning Date

    12 Aug 2025


  • Price Target

    2.28


  • Average Volume

    4.05M


  • Beta

    2


  • Range

    1.15-9.79


  • Industry

    Biotechnology


  • Website

    https://www.humacyte.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

HUMA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$73M

Shape14011%

2026-Revenue

$0.28

Shape-201%

2026-EPS

$15M

Shape163%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

EF Hutton

initialise

Previous: Not converted

2024-09-09

Now: Buy

Piper Sandler

upgrade

Previous: Not converted

2023-08-14

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-0.22
vs -0.19

Q3.23

arrow
arrow

N/A

-0.25
vs -0.25

Q4.23

arrow
arrow

N/A

-0.24
vs -0.21

Q1.24

arrow
arrow

N/A

-0.29
vs -0.22

Q2.24

arrow
arrow

N/A

-0.27
vs -0.22

Q3.24

arrow
arrow

N/A

-0.33
vs -0.25

Q4.24

arrow
arrow

N/A

-0.16
vs -0.24

Q1.25

arrow
arrow

N/A

-0.10
vs -0.29

Q2.25

arrow
arrow

N/A

-0.16
vs -0.27

Q3.25

arrow
arrow

N/A

-0.15
vs -0.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-100%

NA  vs 1.3M

Q3.23

arrow
arrow

-100%

NA  vs 31K

Q4.23

arrow
arrow

NA

10.8M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-33%

7.2M  vs 10.8M

Q1.25

arrow
arrow

NA

517K  vs NA

Q2.25

arrow
arrow

NA

936K  vs NA

Q3.25

arrow
arrow

NA

2.3M  vs NA

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

-37%

-0.37
vs -0.76

Q3.23

arrow
arrow

-70%

-0.70
vs -0.37

Q4.23

arrow
arrow

-185%

-1.85
vs -0.70

Q1.24

arrow
arrow

-122%

-1.22
vs -1.85

Q2.24

arrow
arrow

+200%

2
vs -1.22

Q3.24

arrow
arrow

+62%

0.62
vs 2

Q4.24

arrow
arrow

+40%

0.4
vs 0.62

Q1.25

arrow
arrow

+109%

1.09
vs 0.4

Institutionnal OwnershipShape

status-upQoQ

Q2.23

arrow
arrow

77

77
vs 69

12%

Q3.23

arrow
arrow

86

86
vs 77

12%

Q4.23

arrow
arrow

90

90
vs 86

5%

Q1.24

arrow
arrow

101

101
vs 90

12%

Q2.24

arrow
arrow

130

130
vs 101

29%

Q3.24

arrow
arrow

151

151
vs 130

16%

Q4.24

arrow
arrow

171

171
vs 151

13%

Q1.25

arrow
arrow

175

175
vs 171

2%

Earnings Growth

Latest News